Heather Ann McSharry, Director at Jazz Pharmaceuticals plc (JAZZ), sold 7,858 shares at $152.32 ($1.2M) on 2022-08-08, disclosed to the SEC on 2022-08-09.
Seasonal sale ($1.2M) by Director — this insider has traded JAZZ in August in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $152.32 | 1,179 | $180K | 14.8% |
| 2 | $152.32 | 1,179 | $180K | 14.8% |
| 3 | $154.59 | 5,500 | $850K | 70.3% |
| Total | $153.91 avg | 7,858 | $1.2M | 100% |
| Filing → |
| JAZZ | SELL | 2023-08-15 | $371K | — | Filing → |
| JAZZ | SELL | 2021-08-10 | $418K | — | Filing → |
| JAZZ | SELL | 2020-08-10 | $254K | — | Filing → |